Biologic Therapy

ANAHEIM, Calif. — The use of biologics for asthma will grow as physicians better define who will respond to specific treatments, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Healio highlights some of the most newsworthy research, topics and advancements in orthopedic biologic treatments in 2023. 

Vtama cream 1% may be used in combination with an injectable biologic for the treatment of plaque psoriasis, according to a Schweiger Dermatology Group press release.

Dermatologists are more likely to prescribe standard of care therapies to children with hidradenitis suppurativa compared with non-dermatologists, according to a study.

SAN DIEGO — In patients with psoriatic arthritis, those with female sex are less likely than those with male sex to achieve outcomes in randomized clinical trials for advanced therapies, according to data presented at ACR Convergence 2023.

ANAHEIM, Calif. — Unfamiliarity with biologics to treat uncontrolled asthma was reported by 42% of primary care physicians, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

A new tool using readily available clinical variables to predict psoriatic arthritis risk in patients with psoriasis demonstrated reasonable accuracy and good model performance, according to data published in Arthritis & Rheumatology.

Factors associated with multiple biologic failure in patients with psoriasis may indicate who would benefit from frequent follow-up, according to a study.

Pediatric patients with palmoplantar plaque psoriasis were more likely to use combination treatment due to the inefficacy of biologics as a primary treatment in this indication, according to a study.

LAS VEGAS — As the business of biologic products has continued to grow, scrutiny from the FDA and other federal authorities on the use and promotion of biologics has also increased, according to a speaker.